BackCentessa Pharmaceuticals plc Overview
Centessa Pharmaceuticals plc - ADR

Centessa Pharmaceuticals plc Discounted Cash Flow

DCF Analysis for CNTA.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.48

Current Fair Value

$0.48
98.8% Downside

Overvalued by 98.8% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading